Literature DB >> 22322235

Neonatal iron overload and tissue siderosis due to gestational alloimmune liver disease.

Silvana Bonilla1, Joshua D Prozialeck, Padmini Malladi, Xiaomin Pan, Songtao Yu, Hector Melin-Aldana, Peter F Whitington.   

Abstract

BACKGROUND & AIMS: Gestational alloimmune liver disease is the main cause of the neonatal hemochromatosis phenotype, wherein severe neonatal liver disease is associated with iron overload and extrahepatic tissue siderosis. How fetal liver disease produces extrahepatic siderosis is not known. We hypothesized that fetal liver injury causes deficient hepcidin production and poor regulation of placental iron flux. Under the resulting conditions of iron overload, the tissue pattern of extrahepatic siderosis is determined by the normal expression of proteins involved in the import of non-transferrin-bound iron and the export of cellular iron.
METHODS: Liver and extrahepatic tissues from infants with gestational alloimmune liver disease were examined and compared to normal age-appropriate tissues.
RESULTS: Serum iron indices indicate iron overload and excess non-transferrin bound iron in gestational alloimmune liver disease. The diseased liver showed significantly reduced hepcidin, hemojuvulin, and transferrin gene expression compared to the normal fetal and neonatal liver. Those extrahepatic tissues that are typically involved in pathological siderosis in neonatal hemochromatosis, whether from normal or diseased newborns, consistently expressed solute carrier family 39 (zinc transporter), member 14 (ZIP14) for non-transferrin-bound iron uptake and expressed little ferroportin for iron export.
CONCLUSIONS: Excess non-transferrin-bound iron in gestational alloimmune liver disease may result from fetal liver injury that causes reduced synthesis of key iron regulatory and transport proteins. Whereas, the pattern of extrahepatic siderosis appears to be determined by the normal capacity of various tissues to import non-transferrin-bound iron and not export cellular iron.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322235     DOI: 10.1016/j.jhep.2012.01.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Hepatobiliary quiz-9 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-03

Review 2.  Neonatal hemochromatosis.

Authors:  Amy G Feldman; Peter F Whitington
Journal:  J Clin Exp Hepatol       Date:  2013-11-27

3.  A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients.

Authors:  Michael R Narkewicz; Simon Horslen; Regina M Hardison; Benjamin L Shneider; Norberto Rodriguez-Baez; Estella M Alonso; Vicky L Ng; Mike A Leonis; Kathleen M Loomes; David A Rudnick; Philip Rosenthal; Rene Romero; Girish C Subbarao; Ruosha Li; Steven H Belle; Robert H Squires
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-30       Impact factor: 11.382

4.  Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis.

Authors:  Daniel S Smyk; Maria G Mytilinaiou; Tassos Grammatikopoulos; A S Knisely; Giorgina Mieli-Vergani; Dimitrios P Bogdanos; Diego Vergani
Journal:  Clin Dev Immunol       Date:  2013-09-19

5.  Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction.

Authors:  Sandra L Ross; Kaustav Biswas; James Rottman; Jennifer R Allen; Jason Long; Les P Miranda; Aaron Winters; Tara L Arvedson
Journal:  Front Pharmacol       Date:  2017-11-21       Impact factor: 5.810

6.  Neonatal acute liver failure with pulmonary yellow hyaline membrane and kernicterus.

Authors:  Kei Shing Oh; Hisham F Bahmad; Carole Brathwaite; Amilcar Castellano Sanchez; Monica Recine
Journal:  Autops Case Rep       Date:  2021-05-06

7.  Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation.

Authors:  Karina Lucio de Medeiros Bastos; Caio Robledo Quaio; Fabiana Roberto Lima; Iana Manuelle Araújo; Candice Alves Tavares Araújo; Flávia Balbo Piazzon; Ismael Dale Cotrim Guerreiro da Silva; Gabriel Nuncio Benevides; Ana Cristina Tannuri; Uenis Tannuri; Ramiro Anthero Azevedo; Chong Ae Kim
Journal:  Clin Mol Hepatol       Date:  2018-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.